MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

NCT03230838 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infection
Pyelonephritis

Interventions

DRUG: Ceftolozane/Tazobactam
DRUG: Meropenem

Sponsor

Merck Sharp & Dohme LLC